Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Cholestasis Reversal: Efficacy of IV Fish Oil [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting Phase 2 and Phase 3 results for intravenous fish oil in reversing cholestasis associated with parenteral nutrition and in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous fish oil (intravenous fish oil)

Snippet

Sponsor: Mark Puder | Conditions: Parenteral Nutrition Associated Liver Disease, Short Bowel Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-09-19